The discovery by Morris et al. (1994) of the genes contributing to the t(2;5)(p23;q35) translocation has laid the foundation for a molecular based recognition of anaplastic large cell lymphoma and highlighted the need for a further stratification of T-cell neoplasia. Likewise the detection of anaplastic lymphoma kinase (ALK) genetic lesions among many human cancers has defined unique subsets of cancer patients, providing new opportunities for innovative therapeutic interventions. The objective of this review is to appraise the molecular mechanisms driving ALK-mediated transformation, and to maintain the neoplastic phenotype. The understanding of these events will allow the design and implementation of novel tailored strategies for a well-defined subset of cancer patients.

ALK signaling and target therapy in anaplastic large cell lymphoma / F., Tabbó; A., Barreca; R., Piva; G., Inghirami; R., Bruna; D., Corino; D., Cortese; R., Crescenzo; G., Cuccuru; F., Di Giacomo; A., Fioravanti; M., Ladetto; I., Landra; K., Messana; R., Machiorlatti; B., Martinoglio; E., Medico; M., Mossino; E., Pellegrino; M., Todaro; P., Campisi; L., Chiusa; A., Chiappella; D., Novero; U., Vitolo; Abate, Francesco; Acquaviva, Andrea; Ficarra, Elisa; R., Freilone; M., Chilosi; A., Zamó; F., Facchetti; S., Lonardi; A., De Chiara; F., Fulciniti; C., Doglioni; M., Ponzoni; L., Agnelli; A., Neri; K., Todoerti; C., Agostinelli; P. P., Piccaluga; S., Pileri; B., Falini; E., Tiacci; P., Van Loo; T., Tousseyn; C., De Wolf Peeters; E., Geissinger; H. K., Muller Hermelink; A., Rosenwald; M. A., Pirisand; M. E., Rodriguez; F., Bertoni; M., Boi; I., Kwee. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - (2012). [10.3389/fonc.2012.00041]

ALK signaling and target therapy in anaplastic large cell lymphoma

ABATE, FRANCESCO;ACQUAVIVA, ANDREA;FICARRA, ELISA;
2012

Abstract

The discovery by Morris et al. (1994) of the genes contributing to the t(2;5)(p23;q35) translocation has laid the foundation for a molecular based recognition of anaplastic large cell lymphoma and highlighted the need for a further stratification of T-cell neoplasia. Likewise the detection of anaplastic lymphoma kinase (ALK) genetic lesions among many human cancers has defined unique subsets of cancer patients, providing new opportunities for innovative therapeutic interventions. The objective of this review is to appraise the molecular mechanisms driving ALK-mediated transformation, and to maintain the neoplastic phenotype. The understanding of these events will allow the design and implementation of novel tailored strategies for a well-defined subset of cancer patients.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11583/2506143
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo